Literature DB >> 20690139

Meta-analysis of genome-wide and replication association studies on prostate cancer.

Hong Liu1, Bo Wang, Chunsheng Han.   

Abstract

BACKGROUND: Genome-wide and replication association studies (GWAs) have identified multiple loci at which common variants modestly influence the risk of developing prostate cancer (PCa). To enhance the power to identify loci associated with PCa, we constructed a meta-analysis of GWAs on PCa.
METHODS: Articles evaluating the effects of genome-wide SNPs on PCa were identified by searching the PubMed database. After extraction of relevant data, main and subgroup meta-analyses were performed to assess the effects of relevant SNPs on PCa.
RESULTS: 21 eligible articles containing 71 subgroups were included in this meta-analysis. Significant associations were found between 31 SNPs and PCa. They were rs445114, rs620861, rs983085, rs1016343, rs1447295, rs1859962, rs2660753, rs2710646, rs2735839, rs3760511, rs4242382, rs4430796, rs4962416, rs5945572, rs5945619, rs6470494, rs6501455, rs6983267, rs6983561, rs7000448, rs7214479, rs7501939, rs7920517, rs7931342, rs9364554, rs9623117, rs10090154, rs10486567, rs10896449, rs10993994, and rs16901979. The weighted odds ratios for above SNPs ranged between 0.64 and 1.88 (all P < 0.05). Subgroup analysis further indicated that the significant associations of some SNPs existed only in specific ancestry population (P < 10⁻⁵).
CONCLUSIONS: The current meta-analysis demonstrated the moderate effects of above 31 SNPs on PCa and 14 independent PCa risk loci were identified.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20690139     DOI: 10.1002/pros.21235

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  27 in total

1.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippmann; Howard L Parnes; Paul J Dluzniewski; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz
Journal:  Prostate       Date:  2015-06-05       Impact factor: 4.104

2.  Prostate cancer risk alleles and their associations with other malignancies.

Authors:  Phillip R Cooper; Barry B McGuire; Brian T Helfand; Stacy Loeb; Qiaoyan Hu; William J Catalona
Journal:  Urology       Date:  2011-08-05       Impact factor: 2.649

3.  Common variants at 8q24 are associated with prostate cancer risk in Serbian population.

Authors:  Ana S Branković; Goran N Brajušković; Jovan D Mirčetić; Zorana Z Nikolić; Predrag B Kalaba; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Zoran A Radojičić; Dušanka L J Savić-Pavićević; Stanka P Romac
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

4.  Prostate cancer: improving PSA testing by adjusting for genetic background.

Authors:  Peter T Scardino
Journal:  Nat Rev Urol       Date:  2013-02-19       Impact factor: 14.432

5.  BET1L and TNRC6B associate with uterine fibroid risk among European Americans.

Authors:  Todd L Edwards; Kara A Michels; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-04-19       Impact factor: 4.132

6.  Cancer susceptibility variants and the risk of adult glioma in a US case-control study.

Authors:  Kathleen M Egan; Reid C Thompson; L B Nabors; Jeffrey J Olson; Daniel J Brat; Renato V Larocca; Steven Brem; Paul L Moots; Melissa H Madden; James E Browning; Y Ann Chen
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

7.  Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia.

Authors:  Ke-Sheng Wang; Lingjun Zuo; Daniel Owusu; Yue Pan; Xingguang Luo
Journal:  J Schizophr Res       Date:  2014-08-01

8.  Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.

Authors:  Christine Neslund-Dudas; Albert M Levin; Jennifer L Beebe-Dimmer; Cathryn H Bock; Nora L Nock; Andrew Rundle; Michelle Jankowski; Richard Krajenta; Q Ping Dou; Bharati Mitra; Deliang Tang; Timothy R Rebbeck; Benjamin A Rybicki
Journal:  Cancer Causes Control       Date:  2014-05-07       Impact factor: 2.506

Review 9.  Risk stratification in prostate cancer screening.

Authors:  Monique J Roobol; Sigrid V Carlsson
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

Review 10.  Genome-wide association studies on prostate cancer: the end or the beginning?

Authors:  Rui Chen; Shancheng Ren; Yinghao Sun
Journal:  Protein Cell       Date:  2013-08-27       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.